Discontinued — last reported Q4 '25
AOCI
EquityEli Lilly AOCI increased by 10.2% to -$2.88B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 33.4%, from -$4.32B to -$2.88B. Over 5 years (FY 2020 to FY 2025), AOCI shows an upward trend with a -15.0% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ4 2008
Last reportedQ4 2025
How to read this metric
A negative value (loss) often reflects a strong US dollar impacting international operations or declining values in the company's investment portfolio.
Detailed definition
Accumulated Other Comprehensive Income (Loss) includes gains and losses that are excluded from net income because they h...
Peer comparison
Particularly relevant for multinational corporations with significant overseas revenue and large corporate investment portfolios.
Metric ID:
aociHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$6.29B | -$6.17B | -$4.34B | -$4.23B | -$4.29B | -$4.30B | -$3.84B | -$3.78B | -$3.79B | -$3.78B | -$4.33B | -$4.30B | -$4.38B | -$4.27B | -$4.32B | -$3.77B | -$3.72B | -$3.21B | -$2.88B |
| QoQ Change | — | +1.8% | +29.6% | +2.7% | -1.5% | -0.2% | +10.5% | +1.8% | -0.3% | +0.1% | -14.3% | +0.6% | -1.8% | +2.4% | -1.1% | +12.7% | +1.6% | +13.7% | +10.2% |
| YoY Change | — | — | — | — | +31.8% | +30.4% | +11.5% | +10.6% | +11.6% | +11.9% | -12.5% | -13.8% | -15.6% | -12.9% | +0.1% | +12.2% | +15.1% | +25.0% | +33.4% |
Range-$6.29B – -$2.88B
CAGR-15.9%
Avg YoY Growth+9.3%
Median YoY Growth+11.6%
Current Streak4 quarters growth
AOCI at Other Companies
Frequently Asked Questions
- What is Eli Lilly's aoci?
- Eli Lilly (LLY) reported aoci of -$2.88B in Q4 2025.
- How has Eli Lilly's aoci changed year-over-year?
- Eli Lilly's aoci increased by 33.4% year-over-year, from -$4.32B to -$2.88B.
- What is the long-term trend for Eli Lilly's aoci?
- Over 5 years (2020 to 2025), Eli Lilly's aoci has grown at a -15.0% compound annual growth rate (CAGR), from -$6.50B to -$2.88B.
- What does aoci mean?
- A collection of paper gains or losses on things like investments and currency changes that haven't been finalized yet.